SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA
Author(s) -
Pantelis Sarafidis,
Charles J. Ferro,
Enrique Morales,
Alberto Ortíz,
Jolanta Małyszko,
Radovan Hojs,
Khaled Khazim,
Robert Ekart,
José Manuel Valdivielso,
Denis Fouque,
Gérard M. London,
Ziad A. Massy,
P. Ruggenenti,
Esteban Porrini,
Andrzej Więcek,
Carmine Zoccali,
Francesca Mallamaci,
Mads Hornum
Publication year - 2019
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfz137
Subject(s) - medicine , cardioprotection , diabetes mellitus , kidney disease , disease , endocrinology , myocardial infarction
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom